New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on: January 11,2024

New CAR T-cell immunotherapy shows promising results for treating blood cancer patients

byKing's College LondonUCART19 cellular kinetics and correlation with clinical response. A, Graphical representation of UCART19 kinetic profile in PB of patients with B-ALL in the CALM study

Updated on:January 11,2024

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on: January 22,2024

The tumor environment can affect breast cancer prognosis

byLund UniversityFlowchart of included and excluded patients and representative pictures of each CAV1 staining category in stroma and cytoplasm. Credit:Translational Oncology(2022).

Updated on:January 22,2024

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on: December 28,2023

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Updated on:December 28,2023

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on: January 02,2024

Cancer mortality higher among American Indian and Alaska Native individuals; colorectal cancer before age 50 rising

byAmerican Cancer SocietyResearchers at the American Cancer Society stress improving access to high-quality cancer prevention, early detection, and treatment for this group of individuals. Credi

Updated on:January 02,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on: July 04,2024

Study finds link between Medicaid expansion and equity in cancer care

by Anne Doerr,Yale UniversityCredit: CC0 Public DomainRacial disparities in timely cancer treatment disappeared in states that expanded Medicaid under the Affordable Care Act (ACA), according to

Updated on:July 04,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on: February 19,2024

A cell surface marker for identifying tumor-initiating cells in pancreatic cancer

by Kumamoto UniversityROR1 is a cell surface receptor that promotes hyperproliferation, metastasis, and relapse in PDAC when highly expressed. Suppressing ROR1 reduces PDAC growth. Credit: Masaya

Updated on:February 19,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on: November 10,2024

Fear of cancer recurrence common decades after surviving childhood cancer

by Lori SolomonA third of childhood cancer survivors experience fear of recurrence even decades later, according to a study published online Oct. 3 inJAMA Network Open.Alex Pizzo, from Concordia

Updated on:November 10,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on: February 20,2024

Travel time for breast cancer screening remains long for many women in the US, new study shows

by American Cancer SocietyA new study led by researchers at the American Cancer Society shows travel time to the nearest mammography facility is long for a considerable proportion of women in the

Updated on:February 20,2024

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind

Updated on: January 29,2024

Avoid unnecessary removal of lymph nodes in breast cancer, recommends new study

by Universitätsklinikum HeidelbergRadiation planning CT after axillary lymph node dissection. The arrow shows the clips at the upper border of axillary dissection. No surgical changes are noted behind

Updated on:January 29,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on: March 01,2024

Study confirms curable state between single and widespread cancers

by University of Chicago Medical CenterRalph Weichselbaum, M.D., the Daniel K. Ludwig Distinguished Service Professor, chair of radiation and cellular oncology at UChicago and director of the Lud

Updated on:March 01,2024